首页> 美国卫生研究院文献>other >High Molecular Weight Blood group A Trisaccharide-Polyacrylamide Glycoconjugates As Synthetic Blood Group A Antigens For Anti-A Antibody Removal Devices
【2h】

High Molecular Weight Blood group A Trisaccharide-Polyacrylamide Glycoconjugates As Synthetic Blood Group A Antigens For Anti-A Antibody Removal Devices

机译:高分子量血液将三糖 - 聚丙烯酰胺糖缀合物作为合成血液组抗原抗体去除装置的抗原

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Specific immunoadsorption of blood group antibodies by synthetic antigens immobilized on support matrices in the peri-transplantation period provides a promising solution to hyperacute rejection risk following ABO-incompatible transplantation. In this study, we investigated binding interactions between anti-A antibodies and synthetic blood group A trisaccharide conjugated with polyacrylamide of different molecular weights (30 and 1000 kDa). The glycopolymers were equipped with biotin tags and deposited on streptavidin-coated sensor chips. The affinity and kinetics of anti-A antibodies binding to glycoconjugates were studied using surface plasmon resonance (SPR). The high molecular weight conjugate (Atri-PAA1000-biotin) enhanced antibody binding capacity by two to three fold compared to the low molecular weight conjugate (Atri-PAA30-biotin), whereas varying the carbohydrate content in Atri-PAA1000-biotin (20 mol% or 50 mol%) did not affect antibody binding capacity of the glycoconjugate. The obtained results suggest that immunoadsorption devices, especially hollow fiber-based antibody filters which are limited in available surface area for antigen immobilization, may greatly benefit from the new synthetic high molecular weight polyacrylamide glycoconjugates.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号